domingo, 30 de junio de 2024
Diagnosis: Debt
https://kffhealthnews.org/diagnosis-debt/
More than 100 million people in America — a startling 41% of adults — are saddled with medical bills they cannot pay, according to a KFF Health News investigation with NPR and CBS News. The project exposed that medical debt — rather than fighting disease — is now a defining feature of the nation’s health care system.
When Medical Devices Malfunction
https://kffhealthnews.org/medical-devices-malfunction/
Americans trust the FDA to make sure medical devices are safe and to act swiftly if problems arise. But a year-long investigation by KFF Health News and CBS News revealed that a series of FDA-cleared products, both implanted in the human body and used to treat chronic diseases, have been suspected of contributing to thousands of injuries and patient deaths.
Primary Care Disrupted
https://kffhealthnews.org/primary-care-disrupted/
Known as the “front door” to the health system, primary care is changing. Under pressure from increased demand, consolidation, and changing patient expectations, the model of care no longer means visiting the same doctor for decades. KFF Health News looks at what this means for patients.
Overpayment Outrage KFF Health News / Cox Media Group Investigation
https://kffhealthnews.org/overpayment-outrage/
The Social Security Administration has been overpaying billions of dollars to people, many on disability — then demanding the money back, even if the government made the mistake, an investigation by KFF Health News and Cox Media Group revealed. The reporting has triggered a congressional hearing, additional Senate oversight of the agency, an apology from the head of the SSA to Congress, and an ongoing internal policy review.
Bill of the Month
This crowdsourced investigation by KFF Health News and NPR dissects and explains your medical bills every month in order to shed light on U.S. health care prices and to help patients learn how to be more active in managing costs. Do you have a medical bill that you’d like us to see and scrutinize?
https://kffhealthnews.org/news/tag/bill-of-the-month/
Alcohol rehabilitation and cancer risk: a nationwide hospital cohort study in France
Alcohol rehabilitation and cancer risk: a nationwide hospital cohort study in France
https://www.thelancet.com/collections/psychiatry?dgcid=hubspot_email_infocusalerts-psychiatry_feature%20&parent=001633&startPage=&ContentItemType=fla&utm_campaign=infocusalerts-psychiatry&utm_medium=email&_hsenc=p2ANqtz-9h5XKAqi9xhTsad6rcZbCFdq-mj7uf0MTVRNQKy4mJKRy3ijuU7I2PfVYWY8apG6YlWTIb6PQklh-YMxrWJoMY7fJ_cg&_hsmi=313766710&utm_content=312437395&utm_source=hs_email
The Lancet Psychiatry Commission on Transforming Mental Health Implementation Research
Executive Summary
Effective approaches exist to prevent and treat mental illness and to promote mental health but most people who could benefit from evidence-based interventions (policies, programmes, and individual-level practices or services) do not receive them. Too often, research produces interventions and implementation strategies that are difficult to scale owing to misalignment with the political, cultural, policy, system, community, provider, and individual realities of real-world settings. This Commission considers strategies for transforming how research is done to produce more actionable evidence. It examines how to integrate research and real-world implementation; centre equity in mental health intervention and implementation research; apply a complexity science lens to mental health research; expand designs beyond the randomised clinical trial; and value transdisciplinarity across endeavours. Most mental health implementation research has been done in high-income countries but the Commission’s recommendations incorporate research from low-income and middle-income countries and call for strategies to expand mental health implementation research globally.
https://www.thelancet.com/commissions/implementation-mental-health?dgcid=hubspot_email_infocusalerts-psychiatry_feature_lanpsymentalhealthresearch24&utm_campaign=infocusalerts-psychiatry&utm_medium=email&_hsenc=p2ANqtz-9WLFs2dATjYkFL5_u4BUK0GCuF_oHdSoYwTlkf85jE9YIPV0e2GIzAi_Ei0zN2v6f24hOKR-3Z4FjzRBCjXKxNLNZyJQ&_hsmi=313766710&utm_content=312437395&utm_source=hs_email
sábado, 29 de junio de 2024
Closing of Rural Hospitals Leaves Towns With Unhealthy Real Estate By Taylor Sisk JUNE 26, 2024
https://kffhealthnews.org/news/article/rural-hospital-closures-unhealthy-real-estate/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz--Dlu0VjJ7Qkvf9YT0jgLRXRjuAmEC03IpZQlD1EUVKtDxwg5Um6hadd8RQiYB1N3DsMEomzx0pOzAzEKT40KOwNf9fIg&_hsmi=313690363&utm_content=313690363&utm_source=hs_email
JELLICO, Tenn. — In March 2021, this town of about 2,000 residents in the hills of east Tennessee lost its hospital, a 54-bed acute care facility. Campbell County, where Jellico is located, ranks 90th of Tennessee’s 95 counties in health outcomes and has a poverty rate almost double the national average, so losing its health care cornerstone sent ripple effects through the region.
$2 Million Disbursed to Victims and Community Groups in Wake of Super Bowl Mass Shooting By Peggy Lowe, KCUR and Bram Sable-Smith JUNE 28, 2024
https://kffhealthnews.org/news/article/kcstrong-fund-gunshot-victims-2-million-dollars/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz-_dC20j2PY5KXII1mQr407z0c6ALIUJibw62t9j3njo1CNx2F98faZ0VeD0GHTUDBaodtAM-JugzKdiOQhcnmV1dKTuAw&_hsmi=313690363&utm_content=313690363&utm_source=hs_email
Those were reactions from some of the 20 gunshot victims from the Kansas City Chiefs Super Bowl parade shootings who were awarded $1.2 million from the #KCStrong fund on Thursday, with individuals receiving payments ranging from $22,000 to $100,000.
Republicans Are Downplaying Abortion, but It Keeps Coming Up By Julie Rovner JUNE 28, 2024
https://kffhealthnews.org/news/article/republicans-downplay-abortion-election-issue-voter-opinion/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz-9Bgr05_lbUPtQPJIKSFdKoP5x_2mFs4g_d9JpP89oBXTYG5gMcQLJxagt-aHCOQLPT-MTnsR2HRKZJB1MY3wvCVJhVEg&_hsmi=313690363&utm_content=313690363&utm_source=hs_email
For generations, the GOP campaigned on eliminating the right to an abortion in the United States. Now, torn between a base that wants more restrictions on reproductive health care and a moderate majority that does not, it seems many Republicans would rather take an off-ramp than a victory lap.For generations, the GOP campaigned on eliminating the right to an abortion in the United States. Now, torn between a base that wants more restrictions on reproductive health care and a moderate majority that does not, it seems many Republicans would rather take an off-ramp than a victory lap.
KFF’s New Health Misinformation and Trust Initiative June 13, 2024 From Drew Altman, Ph.D., KFF President and CEO, KFF Health News Founding Publisher
https://www.kff.org/kffs-new-health-misinformation-and-trust-initiative/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz-_SyFOyx6dP_QSgeEVnqHFsc_zr-Lc7U-wnm5XzQXl_UgAQq9btjDFzy_JF-07Ll3wu2tUiUbuFdIuIwV6wNf6TTUoFJg&_hsmi=313690363&utm_content=313690363&utm_source=hs_email
We recently launched a new initiative on Health Misinformation and Trust to monitor the latest developments in health misinformation, poll regularly about how misinformation is affecting Americans, and mobilize the news media interested in health misinformation. As part of the initiative, we’ve created a twice-monthly briefing, the Health Misinformation Monitor, to keep track of the latest developments. In our latest edition of the Monitor, we examine recent Supreme Court decisions that impact health misinformation, and also explore COVID-19 narratives following Dr. Fauci's congressional testimony.
Emergency Abortion Care to Preserve the Health of Pregnant People: SCOTUS, EMTALA, and Beyond Laurie Sobel, Mabel Felix, Usha Ranji, and Alina Salganicoff Published: Jun 27, 2024
https://www.kff.org/policy-watch/emergency-abortion-care-scotus-emtala/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz-_5QYk7LiFlZSlR7WvmtL5RwYqBCsgeXqa9rCDgRUAQhCEi8lL6jqAPmj2wx6aMmsSIlJWCR41o8XySQCL77QCZ1BhI4w&_hsmi=313690363&utm_content=313690363&utm_source=hs_email
After much anticipation, SCOTUS has dismissed the second abortion-related case it heard this term, Moyle v. United States (consolidated with United States v. Idaho). A majority of the justices decided that the Court should not have taken the case at this time and, because of that, there is no ruling on the core questions presented and the case returns to lower courts for further proceedings. The decision also reinstates a District Court’s order blocking enforcement of the Idaho abortion ban where it conflicts with EMTALA, the federal law requiring hospitals to provide stabilizing treatment to patients who present to their emergency rooms. Idaho – like 5 other states – has an abortion ban that includes an exception to save the life of the pregnant person, but no exception for preserving health. Today’s decision does not affect enforcement of bans in any other states. This decision means the Court did not rule on the merits on any of the abortion-related cases this term, a topic of high significance to many voters ahead of the 2024 presidential elections.
SCOTUS Case Could Weaken the Impact of Regulation on Key Patient and Consumer Protections Michelle Long, Justin Lo, and Kaye Pestaina
https://www.kff.org/private-insurance/issue-brief/upcoming-scotus-case-could-weaken-impact-regulation-key-patient-consumer-protections/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz-9oreCO27wg8y2LZ2XQHjO10PtSKRSb8zWan9gJuhGb7cOS96XTsk_7-T_Wex34hafa7voYKnBoCk0Vkhe4HRtnPhesuQ&_hsmi=313690363&utm_content=313690363&utm_source=hs_email
Update: In a 6-3 ruling on June 28, 2024, the US Supreme Court overturned the Chevron deference framework. Federal courts will no longer be required to defer to regulations of administrative agencies that set a reasonable interpretation of unclear laws passed by Congress. A forthcoming analysis will examine some of the implications of the Supreme Court decision for health care.
Unraveling the Mysteries of Biden vs. Trump on Health Care Drew Altman Published: Jun 24, 2024 © 2024 KFF
https://www.kff.org/from-drew-altman/unraveling-the-mysteries-of-biden-vs-trump-on-health-care/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz--A20jn7YuQs61PSZMlCGg0emjhiR_YpPI-33oWS0GIRyNDvGlQ3OJ8Fcds2OysCPJjYCPgVNeI0p1Q1zS5tWAcEXB7Eg&_hsmi=313690363&utm_content=313690363&utm_source=hs_email
We released one of our traditional “side by sides” today comparing President Biden and President Trump on health care. We have done this for every election cycle. This time, however, it was an especially tricky assignment.
Compare the Candidates on Health Care Policy Updated: June 27, 2024 © 2024 KFF
https://www.kff.org/compare-2024-candidates-health-care-policy/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz-8dSmrcECT6BNU0-_t22ut9gTIXuULnaHSxPssKKF2zd0ua9tEeX-nhMaJWUJcBiGe25xP2zNWly376D2U1Hpx6gfXIGw&_hsmi=313690363&utm_content=313690363&utm_source=hs_email
The general election campaign has commenced, spotlighting President Biden and former President Trump as the presumptive nominees for their respective parties and the currently viable contenders for the presidency. While this is not an election like in the past where health care reform is a central issue being debated, health care is an important issue for voters and Biden and Trump have sharply divergent records and positions. This side-by-side analysis serves as a quick resource for understanding each candidate’s record as president, positions, public statements, and proposed policies. It will be continuously updated as new information and policy details emerge throughout the campaign.
viernes, 28 de junio de 2024
Quality improvement lessons learned from National Implementation of the "Patient Safety Events in Community Care: Reporting, Investigation, and Improvement Guidebook". June 26, 2024
https://psnet.ahrq.gov/issue/quality-improvement-lessons-learned-national-implementation-patient-safety-events-community
Quality improvement lessons learned from National Implementation of the "Patient Safety Events in Community Care: Reporting, Investigation, and Improvement Guidebook".
Sullivan JL, Shin MH, Chan J, et al. Health Serv Res. 2024;Epub May 8.
Effective implementation of patient safety practices remains an organizational challenge. This qualitative study explored lessons learned and opportunities for improvement based on nationwide implementation of the VA Patient Safety Events in Community Care: Reporting, Investigation, and Improvement Guidebook aimed at standardizing patient safety practices in the Veterans’ Affairs (VA) Community Care Network. Researchers conducted semi-structured interviews with patient safety officers, quality managers, and community care staff, and identified barriers and facilitators to Guidebook implementation (e.g., resource availability, organizational culture). Qualitative findings underscored the importance of leadership engagement, role clarity, and effective communication.
What is diagnostic safety? A review of safety science paradigms and rethinking paths to improving diagnosis. June 26, 2024
https://psnet.ahrq.gov/issue/what-diagnostic-safety-review-safety-science-paradigms-and-rethinking-paths-improving
What is diagnostic safety? A review of safety science paradigms and rethinking paths to improving diagnosis.
Choi JJ. Diagnosis (Berl). 2024.
Improving diagnostic safety requires a variety of approaches. This review presents Safety-I, Safety-II, and Safety-III approaches do not only identify and reduce diagnostic errors, but also to improve diagnostic performance.v
Listen to me, I really am sick! Patient and family narratives of clinical deterioration before and during rapid response system intervention. June 26, 2024
https://psnet.ahrq.gov/issue/listen-me-i-really-am-sick-patient-and-family-narratives-clinical-deterioration-and-during
Listen to me, I really am sick! Patient and family narratives of clinical deterioration before and during rapid response system intervention.
Bucknall TK, Guinane J, McCormack B, et al. J Clin Nurs. 2024;Epub May 31.
Rapid response teams (RRTs) or medical emergency teams (METs) are activated before clinical deterioration, or as soon as deterioration is recognized. In some hospitals, patients and families can activate an MET, and understanding their perspectives is important. For this study, patient and family perspectives of MET activation were sought prior to implementation of patient and family activated escalation system (PFAES) in two Australian hospitals. The overarching theme was help seeking, with four subthemes: identifying deterioration, voicing concerns, being heard, and trust and expectation.
AHRQ Grantee Profiles
AHRQ Grantee Profiles: These profiles highlight AHRQ research training grantees whose work has led to significant changes in health care policy and notably influenced research and practice. AHRQ supports a range of research training and career development grant programs that help emerging health services researchers better understand, improve, and share knowledge about how health care is delivered in the United States.
Maximizing Safety, Value, and Patient Preferences for Treating Chest Pain
Maximizing Safety, Value, and Patient Preferences for Treating Chest Pain: Grantee Profile
AHRQ Grantee Simon Mahler Explores Strategies To Safely and Efficiently Treat Patients With Chest Pain
People who go to an emergency department with chest pain are often admitted for further observation, testing or treatment. However, most patients do not need to be admitted and can safely go home. Simon A. Mahler, M.D., a professor and vice chair of research at Wake Forest University School of Medicine’s Department of Emergency Medicine, is using AHRQ funding to test a strategy he calls CARE, for Cardiovascular Ambulatory Rapid Evaluation. He aims to find out if moderate-risk patients can be sent home safely and receive outpatient clinic follow-up within 72 hours in lieu of being admitted immediately. Access more information about Dr. Mahler’s work as a first-time grantee,
NIH-Sponsored Trial of Enterovirus D68 Therapeutic Begins Monoclonal Antibody Developed from Blood of Recovering Patients
https://www.niaid.nih.gov/news-events/nih-sponsored-trial-enterovirus-d68-therapeutic-begins?utm_campaign=+61168066&utm_content=&utm_medium=email&utm_source=govdelivery&utm_term=
A NIAID-sponsored clinical trial has begun to evaluate the safety of an investigational monoclonal antibody to treat enterovirus D68 (EV-D68), which can cause severe respiratory and polio-like neurological disease – such as acute flaccid myelitis (AFM). Scientists are striving to better understand AFM, which has emerged in the United States with spikes in cases every other year, primarily in the late-summer months over the last decade. The U.S. Centers for Disease Control and Prevention (CDC) identified increases in AFM cases in 2014, 2016, and 2018. There are no Food and Drug Administration-approved treatments for severe EV-D68 infection or AFM. Clinical Trial NCT06444048 will enroll 36 healthy volunteers ages 18 to 49 at Vanderbilt University Medical Center and the University of Maryland.
FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test Test Enables Single-Visit Testing and Treatment for Hepatitis C
https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-first-point-care-hepatitis-c-rna-test
Today, the U.S. FDA has approved the first rapid hepatitis C virus test for the U.S. market that can be used in patient care settings. The test, which was validated in part by the NIH RADx Tech program with funding from CDC, can provide results in about one hour, meaning patients with a positive test can begin treatment right away.
Although a cure for hepatitis C is available, many people with the potentially deadly disease are not aware that they have it and do not receive treatment. This is partly because hepatitis C testing has been a lengthy process before results are available and requires follow-up appointments. But now, it will be possible to obtain a test result and start a course of treatment at the same health visit.
https://www.nibib.nih.gov/about-nibib/directors-corner
Arm in Arm with AcademyHealth, AHRQ is Poised to Build on Successes in Health Services Research
Arm in Arm with AcademyHealth, AHRQ is Poised to Build on Successes in Health Services Research: Third and final blog post about commemorating AHRQ's 35th anniversary year.
2024 Annual Research Meeting Today’s research driving tomorrow’s outcomes
https://academyhealth.org/ARM
AHRQ Director Robert Otto Valdez, Ph.D., M.H.S.A., cites examples of how AHRQ’s ongoing work in data and analytics, health systems research, and practice improvement continues to resonate with patients, health system leaders, clinicians, researchers, caregivers, and others in the third and final installment in a series of blog posts commemorating AHRQ’s 35th anniversary. The blog post also highlights AHRQ’s participation in AcademyHealth’s upcoming Annual Research Meeting, June 29 to July 2. Dr. Valdez congratulates AcademyHealth’s outgoing president and CEO Dr. Lisa Simpson and expresses his enthusiasm to work with new AcademyHealth president and CEO Dr. Aaron Carroll. Access the full blog post, along with the two earlier anniversary blogs: AHRQ Commemorates 35 Years as an Independent Science Agency and Continuing a 35-Year History, AHRQ Pursues Vital Pathways to Improve Patient Care.
Mindfulness-Based Interventions for Mental Health and Wellbeing in Children and Adolescents: A Systematic Review
Mindfulness-Based Interventions for Mental Health and Wellbeing in Children and Adolescents: A Systematic Review: This systematic review will assess the effectiveness and potential harms of MBIs in children and adolescents, used for the prevention or treatment of mental health conditions and for improving general wellbeing.
This systematic review will assess the effectiveness and potential harms of mindfulness-based interventions in children and adolescents, used for the prevention or treatment of mental health conditions and for improving general wellbeing.
(Section 944 (c) of the Public Health Service Act [42 U.S.C. 299c 3(c)] requires that information collected for research conducted or supported by AHRQ that identifies individuals or establishments be used only for the purpose for which it was supplied unless they consent to the use of the information for another purpose.)
Mental Health and Occupational Stress in the Emergency Medical Services and 911 Workforce
Mental Health and Occupational Stress in the Emergency Medical Services and 911 Workforce: We addressed four Key Questions (KQs) related to: incidence, prevalence, and severity of mental health and occupational stress issues (KQ1); benefits and harms of interventions to promote resistance and resilience regarding these issues (KQ2); contextual and implementation factors of studies with effective EMS and telecommunicator workforce practices to prevent, recognize, and treat mental health and occupational stress issues (KQ3); and future research that is needed to close existing gaps regarding prevention, recognition, and treatment of mental health issues and occupational stress issues in the EMS and telecommunicator workforces (KQ4).
This systematic review addresses the mental health of the Emergency Medical Services (EMS) and 911 telecommunicator workforces. We address four Key Questions related to the: (1) incidence, prevalence, and severity of mental health and occupational stress issues; (2) benefits and harms of interventions to promote resistance and resilience regarding these issues; (3) contextual and implementation factors of studies with effective EMS and telecommunicator workforce practices to address these issues; and (4) future research that is needed to close existing gaps regarding addressing mental health and occupational stress issues in the EMS and telecommunicator workforces.
FDA Opens Doors for More Treatments for Rare Diseases through the New START Pilot Program
https://www.fda.gov/drugs/our-perspective/fda-opens-doors-more-treatments-rare-diseases-through-new-start-pilot-program
By: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research and Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
jueves, 27 de junio de 2024
Care Following Nonfatal Overdose Among Medicare Beneficiaries – Study Identifies Interventions and Gaps
https://www.samhsa.gov/newsroom/press-announcements/20240617/federal-study-examines-care-following-nonfatal-overdose-among-medicare-beneficiaries?utm_source=SAMHSA&utm_campaign=96c6fddb8f-EMAIL_CAMPAIGN_2024_06_17_03_57&utm_medium=email&utm_term=0_-96c6fddb8f-%5BLIST_EMAIL_ID%5D&utm_source=SAMHSA&utm_campaign=f79b5a1f21-EMAIL_CAMPAIGN_2024_06_26_02_07&utm_medium=email&utm_term=0_-f79b5a1f21-%5BLIST_EMAIL_ID%5D
Researchers from SAMHSA, the National Institutes of Health’s (NIH) National Institute on Drug Abuse (NIDA), Centers for Medicare & Medicaid Services (CMS), and the Centers for Disease Control and Prevention (CDC) found that among a cohort of 137,000 Medicare beneficiaries who experienced a nonfatal overdose in 2020, almost 24,000 (17.4%) experienced a subsequent nonfatal overdose, and about 1,300 (1%) died from overdose in the following year. Results were published recently in JAMA Internal Medicine, identifying both effective interventions and significant gaps in care.
New and Improved Way to Order 988 Suicide & Crisis Lifeline Print Materials
https://orders.gpo.gov/SAMHSA988/Pubs.aspx?utm_source=SAMHSA&utm_campaign=2ba7301ed8-EMAIL_CAMPAIGN_2024_06_20_05_29&utm_medium=email&utm_term=0_-2ba7301ed8-%5BLIST_EMAIL_ID%5D&utm_source=SAMHSA&utm_campaign=f79b5a1f21-EMAIL_CAMPAIGN_2024_06_26_02_07&utm_medium=email&utm_term=0_-f79b5a1f21-%5BLIST_EMAIL_ID%5D
SAMHSA is pleased excited to offer a new one-stop-shop website for ordering 988 awareness print materials. The new website lets you order multiple types of products and multiple packages of products all from a single page. After you place your order, you will receive a confirmation number from GPO (the U.S. Government Publishing Office). Once your package(s) have shipped, you will receive a tracking number from UPS. You can expect your order to take up to three weeks to arrive.
Office Hours — Virtual Open Forum Thursday, July 11, 2024 5 p.m. ET
https://opioidresponsenetwork.org/events/?utm_source=SAMHSA&utm_campaign=f79b5a1f21-EMAIL_CAMPAIGN_2024_06_26_02_07&utm_medium=email&utm_term=0_-f79b5a1f21-%5BLIST_EMAIL_ID%5D#event=77626988;instance=20240711170000?popup=1
Drop-in Office Hours are hour-long, online, open forum sessions where clinical providers and staff supporting those with substance use can drop in anytime with addiction-related questions or brief de-identified challenging cases for discussion. Each session will be moderated by two clinical educators, and some sessions may have a guiding topic for discussion (off-topic questions are still welcome!). Sessions will be held on the 2nd Thursday of each month from 5-6 p.m. EST (with some exceptions).
Stimulants 101 — Webinar Thursday, July 11, 2024 2 p.m. ET
https://opioidresponsenetwork.org/events/?utm_source=SAMHSA&utm_campaign=f79b5a1f21-EMAIL_CAMPAIGN_2024_06_26_02_07&utm_medium=email&utm_term=0_-f79b5a1f21-%5BLIST_EMAIL_ID%5D#event=77626972;instance=20240711140000?popup=1
This one-hour training is intended to provide an overview of stimulant use disorders. Topics include stigma, pharmacology, and physiology of methamphetamines and cocaine, identifying stimulant overdose (overamping), managing acute stimulant intoxication, de-escalation techniques, and evidence-based treatment for people with stimulant use disorders.
Addiction 101 — Webinar Tuesday, July 9, 2024 2 p.m. ET
https://opioidresponsenetwork.org/events/?utm_source=SAMHSA&utm_campaign=f79b5a1f21-EMAIL_CAMPAIGN_2024_06_26_02_07&utm_medium=email&utm_term=0_-f79b5a1f21-%5BLIST_EMAIL_ID%5D#event=77626957;instance=20240709140000?popup=1
This training will provide the foundational knowledge on addiction as a chronic medical condition and an overview of evidence-based interventions, including medications for addiction treatment (MAT).
Save the Date: Clinical Community Partnerships to Support Behavioral Health for Service Members, Veterans, and their Families Tuesday July 30, 1 p.m. ET
https://prainc.zoom.us/webinar/register/WN_oB777GE6RDi43nDYDpCAWQ?utm_source=SAMHSA&utm_campaign=037f83097c-EMAIL_CAMPAIGN_2024_06_11_02_39&utm_medium=email&utm_term=0_-037f83097c-%5BLIST_EMAIL_ID%5D&utm_source=SAMHSA&utm_campaign=f79b5a1f21-EMAIL_CAMPAIGN_2024_06_26_02_07&utm_medium=email&utm_term=0_-f79b5a1f21-%5BLIST_EMAIL_ID%5D#/registration
Join us for an informative webinar on how clinical community partners can work together to support the behavioral health needs of service members, Veterans, and their families. You will hear from Federal and community-based speakers on the following topics:
The Veterans Comprehensive Prevention, Access to Care, and Treatment (COMPACT) Act of 2020
https://news.va.gov/press-room/va-provides-free-emergency-suicide-prevention-care-to-nearly-50000/?utm_source=SAMHSA&utm_campaign=037f83097c-EMAIL_CAMPAIGN_2024_06_11_02_39&utm_medium=email&utm_term=0_-037f83097c-%5BLIST_EMAIL_ID%5D&utm_source=SAMHSA&utm_campaign=f79b5a1f21-EMAIL_CAMPAIGN_2024_06_26_02_07&utm_medium=email&utm_term=0_-f79b5a1f21-%5BLIST_EMAIL_ID%5D
Certified Community Behavioral Health Clinics (CCBHCs) services for Veterans
https://www.samhsa.gov/certified-community-behavioral-health-clinics?utm_source=SAMHSA&utm_campaign=037f83097c-EMAIL_CAMPAIGN_2024_06_11_02_39&utm_medium=email&utm_term=0_-037f83097c-%5BLIST_EMAIL_ID%5D&utm_source=SAMHSA&utm_campaign=f79b5a1f21-EMAIL_CAMPAIGN_2024_06_26_02_07&utm_medium=email&utm_term=0_-f79b5a1f21-%5BLIST_EMAIL_ID%5D
Save the Date: Continuous and Collaborative: Best Practices for Family Treatment Court Screening & Assessment — Webinar July 16, 1:30 p.m. ET
https://us06web.zoom.us/webinar/register/WN_7qSy0PjuQ1eanxiAXnuRtw?utm_source=SAMHSA&utm_campaign=2831e30557-EMAIL_CAMPAIGN_2024_06_24_01_53&utm_medium=email&utm_term=0_-2831e30557-%5BLIST_EMAIL_ID%5D&utm_source=SAMHSA&utm_campaign=f79b5a1f21-EMAIL_CAMPAIGN_2024_06_26_02_07&utm_medium=email&utm_term=0_-f79b5a1f21-%5BLIST_EMAIL_ID%5D#/registration
Family treatment court (FTC) teams often think of “screening and assessment” as a task to complete in the early stages of a case. While vital to inform initial service delivery, screening and assessment processes must be collaborative and continuous to respond to evolving parent and child strengths and needs. This SAMHSA’s GAINS Center webinar will encourage FTC teams to conduct an “assessment inventory” to understand what tools are being used, when, and by whom, and how to collaborate to best use the information without overburdening families.
Arm in Arm with AcademyHealth, AHRQ is Poised to Build on Successes in Health Services Research
Arm in Arm with AcademyHealth, AHRQ is Poised to Build on Successes in Health Services Research: Third and final blog post about commemorating AHRQ's 35th anniversary year.
Can screening for food insecurity make a difference for patients? The jury is out By Alia Sajani June 25, 2024
https://www.statnews.com/2024/06/25/food-insecurity-screening-uspstf-evidence-gaps/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-9-ciqIxPhrMzsZyWBbowDdBZmfR2Vg4FTakIjLnbi7L_wp7IvIBHiJa_CZCPka3FaaXx7i_RhSiXWttzqKfYWsEi_EdQ&_hsmi=313187806&utm_content=313187806&utm_source=hs_email
“I” for “Insufficient”: Does it help when doctors screen for food insecurity?
The U.S. Preventive Services Task Force found no strong evidence that screening for food insecurity in primary care settings actually improves people’s health outcomes, it wrote in a draft recommendation published yesterday. The team of experts labeled the statement with an “I,” meaning there was insufficient evidence for the intervention. Instead, they suggested clinicians continue having discussions with patients about food insecurity and connecting them with resources available in their communities.
“Food insecurity is a complex social risk,” Tumaini Coker, who served on the task force, told STAT’s Alia Sajani. People who don’t have access to nutritious food may also struggle to pay for transportation or housing, which complicates the task of figuring out the impact of food interventions on their own. Read more from Alia on how experts considered the sticky issue.
AI and rural health care: A paradigm shift in America’s heartland By Bill GassenJune 26, 2024
https://www.statnews.com/2024/06/26/ai-rural-health-care-paradigm-shift/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-99lV0MvFSNvvWwnza7txCCT8wq7FcljZ521Ai2aYzd51Bt2PaD29Cu8G3g3URDNfmzBLO6PC7rDqGS4UfI4Gw02hZPng&_hsmi=313187806&utm_content=313187806&utm_source=hs_email
A recent working paper by the National Bureau of Economic Research noted that artificial intelligence is being used in some “unlikely places,” including the Midwest. Who’s calling who unlikely? Bill Gassen, president and CEO of the largest rural health system in the U.S., argues in a new First Opinion essay that health care providers in rural America are pioneering new uses of AI in their practices. While much of the nation is debating the future of AI, he predicts that its impact on rural health care will be consequential.
Recruiting and retaining clinicians to work in understaffed specialities across rural America is one of the greatest demographic challenges in the region. AI can not only help streamline administrative tasks, said Gassen, but soon clinical decision-support tools could help to identify serious health threats, improve diagnoses, and calibrate the precision of medical treatments. Read more from Gassen on what’s really happening with AI in rural America.
NIST Seeks Public Input on Draft Roadmap for USG National Standards Strategy for CET Submit comments by July 12, 2024, on the draft U.S. Government National Standards Strategy for Critical and Emerging Technology (USG NSSCET) Implementation Roadmap. June 26, 2024
https://www.nist.gov/news-events/news/2024/06/nist-seeks-public-input-draft-roadmap-usg-national-standards-strategy-cet
The National Institute of Standards and Technology (NIST) is seeking input from the public on the development of a draft Implementation Roadmap for the United States Government National Standards Strategy for Critical and Emerging Technology (USG NSSCET).
The draft Implementation Roadmap can be reviewed on the NIST website.
Please send comments to sco@nist.gov.
We request that all comments are submitted by July 12, 2024. Do not include personally identifiable information in submissions; submit only information that you wish to make available publicly.
https://www.nist.gov/system/files/documents/2024/06/26/USG%20NSSCET_REPORT_v6_26.pdf
Supreme Court rejects Purdue bankruptcy plan The ruling means the company and its creditors — numerous states, cities and counties — will have to negotiate a new settlement. Ed Silverman By Ed Silverman 2 hr ago
https://www.statnews.com/?p=1175106&utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-8FSIrQ5ZvcxSgGb9gvk8ccEK425rJWASFX3gM-bx7KjytmPJOQwvJM0-GUYAUgTQsQplMOekDGPwnwxiEfv2GcESMvKA&_hsmi=313371527&utm_content=313371527&utm_source=hs_email
Q&A: Lessons from the Bush administration bird flu response
In 2005, Mike Leavitt had been the secretary of the Department of Health and Human Services for only a couple months when he first heard about an avian flu outbreak that began in Asia and eventually spread to North Africa, Turkey, and Europe. He was so worried that he bought 200 copies of a book on the 1918 flu pandemic, hand delivering one to then-President George W. Bush. (Leavitt says Bush read it.)
In an interview with STAT’s Rachel Cohrs Zhang, Leavitt reflects on his response to that bird flu outbreak, which was never detected on American soil — and never in dairy cattle like we’re seeing now. Read the interview.
Three months into bird flu outbreak in U.S. dairy cows, experts see deep-rooted problems in response
Andrew Joseph
Rachel Cohrs Zhang
Helen Branswell
Megan Molteni
By Andrew Joseph , Rachel Cohrs Zhang , Helen Branswell , and Megan Molteni
https://www.statnews.com/2024/06/26/bird-flu-outbreak-avian-flu-containment-h5n1-eradication-in-cattle/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-8_qGwTy-lu1iE2o_S6VPvcPkRSxWRy_vfeLBMEYesykwvfgkoIiEvPBz9L6Mp5xaKs1WGfu26aPVJgTddozEimfmiZig&_hsmi=313371527&utm_content=313371527&utm_source=hs_email
June 26, 2024
FDA issues long-awaited draft guidance for enrolling more people of color in clinical trials John Wilkerson By John Wilkerson June 26, 2024
https://www.statnews.com/2024/06/26/fda-guidance-diversity-clinical-trials/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-9_3wniEQiMdVHVlO-qdxNXi7Bb-1MdG4sNlX8UCGpoROogBWjeWO9kK3KTlIwFrW8t0JJX4jG12olIdxMeaptRlMGhGA&_hsmi=313371527&utm_content=313371527&utm_source=hs_email
How to fix the ‘fundamental flaws’ that underlie racial health inequity
To eliminate the longstanding racial and ethnic health inequities that plague the U.S., Congress needs to provide affordable health insurance for all, federal agencies need to enforce existing laws against discrimination, and researchers need to improve collection of racial and ethnic data, according to a new report released yesterday by the National Academies of Science, Engineering, and Medicine.
The report comes two decades after a groundbreaking 2003 report, also from NASEM, laid bare the realities of structural racism in health care: People of color receive worse treatment, regardless of factors like income or education. Unfortunately, not much has changed in the ensuing decades, the authors wrote, echoing findings from a 2022 investigation by STAT’s Usha Lee McFarling. Read more from Usha on the new report and the authors’ recommendations.
(And speak of the devil, just yesterday the FDA issued draft guidance on enrolling more people of color in clinical trials.) (It is six months late.)
National Academies proposes reimagining health care to fix ‘fundamental flaws’ that underlie inequity
Usha Lee McFarling
By Usha Lee McFarling June 26, 2024
https://www.statnews.com/2024/06/26/national-academies-report-ending-unequal-treatment-health-inequity/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-96GcEtY6ZxMxpw8YqYD2R5P09fEt64v-Ml7rXSi1GKv46x8NM7mETy_I9TwoASoBQwmToXbCfEZzLZIX36nR4rXQt8KQ&_hsmi=313371527&utm_content=313371527&utm_source=hs_email
20 years ago, a landmark report spotlighted systemic racism in medicine. Why has so little changed?
Usha Lee McFarling
By Usha Lee McFarling
https://www.statnews.com/2022/02/23/landmark-report-systemic-racism-medicine-so-little-has-changed/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-_hbYI19MMmiPgCOhm-AK1iv7ul9YLaueVD714Ot1ls0Q7t6-Wye6ST9dsKpQzmQcAAGJmlAIdOF4bT1UXNExgfs87d0g&_hsmi=313371527&utm_content=313371527&utm_source=hs_email
Feb. 23, 2022
Eating rocks: The case for early integration of medical ethics into AI product development By Rebecca Soskin Hicks and Amelia Burke-GarciaJune 27, 2024
https://www.statnews.com/2024/06/27/medical-ethics-early-integration-ai-health-product-development/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-_2MIz4-q4BRs67hHt96z6VX5wj_jwIqJIodpg-SYU4v_W9dT_eI-vJTrEjB0W5Yey8KU4ggeaYsg7Pjv-HdGzTqbG38Q&_hsmi=313371527&utm_content=313371527&utm_source=hs_email
You’ve probably noticed that Google recently integrated Gemini, its new large language model, into its search engine. This could someday become a critical tool for people going to Google with health questions, which happens 70,000 times per minute. But in a new First Opinion essay, two authors say that the technology isn’t quite there yet. See: that time Gemini told a user that “geologists recommend eating at least one small rock each day.”
There are four fundamental principles of medical ethics — non-maleficence, beneficence, autonomy, and justice — that clinicians and researchers use to make morally sound judgments. AI products that are intended to or may produce health information or medical advice should not be exempt from following these ethical principles, the authors write.
Supreme Court rejects challenge to Biden’s use of bully pulpit to fight Covid misinformation Sarah Owermohle By Sarah Owermohle June 26, 2024
https://www.statnews.com/2024/06/26/supreme-court-white-house-social-media-covid-misinformation/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz--dXUqVOgr8EFiI2J6UHKgz13zcB7wkOLld-C308KKasxZcU8_b77FYHp0zAuatF5sECK97e_THNG6oL8y_eDnfFgfFnw&_hsmi=313371527&utm_content=313371527&utm_source=hs_email
All the health news you need from D.C. ahead of tonight’s debate
The first presidential debate of the year between President Biden and former President Trump is set to take place this evening (9 pm ET, watch wherever you watch your debates). The duel comes after a big week of health news in D.C., where my STAT colleagues told me they are tracking a few key issues:
Reproductive rights: We know where Biden stands and we know Trump backs states’ rights (except when they go “too far”). But between the recent mifepristone decision and the federal government’s clash with Idaho abortion law, where does Trump draw his line?
Supreme Court unanimously rejects challenge to mailed abortion pills
Sarah Owermohle
By Sarah Owermohle June 13, 2024
https://www.statnews.com/2024/06/13/supreme-court-mifepristone-mailed-abortion-pills/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz--N1tu5wvxqcv5K2ENALLfJhDRXBbetJHMm_glItsZ9zIWSm04F-UP1kNtoBc1QnWQugH942h3iEVQMWGUbcG-pBJnDKw&_hsmi=313371527&utm_content=313371527&utm_source=hs_email
The Supreme Court appears set to reject Idaho’s near-total abortion ban
Sarah Owermohle
By Sarah Owermohle June 26, 2024
https://www.statnews.com/2024/06/26/supreme-court-emtala-idaho-abortion-ban-ruling/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-8peK396BRvbaBqPInSXLTw_WCzy4zv-Cu2RJelW5YO63_NJiqTvJQAyXJHeV27__XlXVKe9NP27cCDEvAqAY-SO58W8w&_hsmi=313371527&utm_content=313371527&utm_source=hs_email
Obamacare: Trump has railed repeatedly against the Affordable Care Act, but denied he’s looking to revisit a potential appeal. Biden will want to emphasize the law’s popularity and repeal-and-replace’s total failure.
Trump surrogates hint at how he could reshape U.S. health care policy
Sarah Owermohle
By Sarah Owermohle
https://www.statnews.com/2024/04/23/trump-health-care-policy/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz--ExX893QpD5snBdML0gyCDYGYHYhFAkFRmfTrhO8mNZGVx_5YNDwQxqzws-SCJutsDo_B4lo7O9e84gvFTgeng7TH1IA&_hsmi=313371527&utm_content=313371527&utm_source=hs_email
The age-old old age debate: Looming over tonight’s debate is the growing — and longtime — conversation about both candidates’ age and mental acuity.
I’ve reported on the health of every president since Reagan. Here’s what I think about Trump and Biden
By Lawrence K. AltmanFeb. 16, 2024
https://www.statnews.com/2024/02/16/trump-biden-dementia-cognitive-health-lawrence-altman-presidential-history/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz--gT9DOZMYCElf0_5VYXWK6cH56UKesXakBfMCdN4VIF75R9c4nMvQUn3Gahi8VAUJBzy4A8aVa3OzWGRyqNREgDFLFIA&_hsmi=313371527&utm_content=313371527&utm_source=hs_email
Meanwhile, the Supreme Court yesterday rebuffed states and anti-lockdown advocates who said the government violated their First Amendment rights by asking social media giants to remove or limit coronavirus misinformation. And in the House, a panel proposed a new strategy for Medicare to cover weight loss drugs for older adults.
House panel proposes new strategy for Medicare to cover weight loss drugs Wegovy, Zepbound
Rachel Cohrs Zhang
By Rachel Cohrs Zhang June 26, 2024
https://www.statnews.com/2024/06/26/new-plan-medicare-coverage-weight-loss-drugs-wegovy-zepbound/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz--Qt0c3L-THkOlCPMEBbOET5sp2ngT9Z5NRo8vnBDX_YHcD1zNGOxx4qtbBfMkhUO02BOUhVXDXuTRab7dHGh9EdzPimg&_hsmi=313371527&utm_content=313371527&utm_source=hs_email
Real-World Evidence Submissions to the Center for Biologics Evaluation and Research & the Center for Drug Evaluation and Research
https://www.fda.gov/science-research/real-world-evidence/real-world-evidence-submissions-center-biologics-evaluation-and-research-center-drug-evaluation-and?utm_medium=email&utm_source=govdelivery
Today, the U.S. Food and Drug Administration posted a public report on submissions to the Center for Biologics Evaluation and Research (CBER) and the Center for Drug Evaluation and Research (CDER) that contain real-world evidence (RWE).
The use of real-world data (RWD) to improve the efficiency of drug and biologic development programs that rely on traditional clinical trials is well established and encouraged by FDA. This is the first annual report describing submissions to CBER and CDER that contain analyses of RWD to generate RWE intended to support regulatory decision-making about a drug or biological product’s effectiveness or safety. The report meets an agency commitment under the Prescription Drug User Fee Act (PDUFA VII).
IMDRF 26th Session | September 16-20, 2024 | Seattle, Washington
https://events.espinc-usa.com/imdrf092024/begin?utm_medium=email&utm_source=govdelivery
The U.S. Food and Drug Administration (FDA), as the Chair and Secretariat of the International Medical Device Regulators Forum (IMDRF), will host the 26th Session of the IMDRF in Seattle, Washington, on September 16-20, 2024. Medical device stakeholders — including regulators, industry, academia, and the media — are invited to attend a free event that is open to the public, virtually or in-person, on September 16-17. The last three days (September 18-20) are for IMDRF invitees only.
When: September 16-17, 2024 (Open to the public. To attend, please register below)
What attendees can expect: Stakeholders from across the international medical device community will exchange information, generate ideas, and hear updates on IMDRF’s various working groups as they strive to accelerate international medical device regulatory harmonization and convergence. Check out the agenda:
Day One: IMDRF Joint Workshop
Day Two: IMDRF Stakeholder Open Forum
Attend in-person or virtually: The event will be held at the Seattle Marriott Waterfront, located at 2100 Alaskan Way, Seattle, Washington. Please note that space is limited for in-person attendance and early registration is encouraged. You can also attend the meeting by livestream.
Deadline to register: August 26, 2024
FDA Guidance Provides New Details on Diversity Action Plans Required for Certain Clinical Studies
https://www.fda.gov/news-events/press-announcements/fda-guidance-provides-new-details-diversity-action-plans-required-certain-clinical-studies?utm_medium=email&utm_source=govdelivery
On Wednesday, June 26, 2024, the U.S. Food and Drug Administration issued a draft guidance, “Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies,” to assist medical product sponsors in submitting Diversity Action Plans to support certain clinical studies. Diversity Action Plans are intended to increase clinical study enrollment of participants of historically underrepresented populations to help improve the data the agency receives about the patients who may potentially use the medical product.
Enhancing diversity within clinical studies not only facilitates broader applicability of results across a broad spectrum of patient populations, but also enhances understanding of the disease or medical product under study, thus providing valuable insights to inform the safe and effective use of the medical product among patients.
“Participants in clinical trials should be representative of the patients who will use the medical products,” said FDA Commissioner Robert M. Califf, M.D. “The agency’s draft guidance is an important step—and one of many ongoing efforts—to address the participation of underrepresented populations in clinical trials to help improve the data we have about patients who will use the medical products if approved.”
AHRQ’s CAHPS Surveys: The Rationale for Case Mix and Mode Adjustments (Webcast)
AHRQ’s CAHPS Surveys: The Rationale for Case Mix and Mode Adjustments (Webcast): The webinar will discuss the rationale for adjusting CAHPS survey results by case mix and distribution mode. Speakers will address common misunderstandings about applying case mix and mode adjustments, situations that merit factoring in adjustments to data results, typical variables used to make adjustments, and how adjusters differ across various CAHPS surveys.
Now Posted: June 5 Webcast on CAHPS Surveys - The Rationale for Case Mix and Mode Adjustments
This webcast from AHRQ’s Consumer Assessment of Healthcare Providers and Systems (CAHPS®) program discussed the rationale for adjusting CAHPS survey results by case mix and distribution mode. Speakers addressed common misunderstandings about applying case mix and mode adjustments, situations that merit factoring in adjustments to data results, typical variables used to make adjustments, and how adjusters differ across various CAHPS surveys.
Speakers:
Jonathan Bakdash, Ph.D., Agency for Healthcare Research and Quality
Marc Elliott, Ph.D., RAND Corporation
Elizabeth Goldstein, Ph.D., Centers for Medicare and Medicaid Services (CMS)
Dale Shaller, M.P.A, Shaller Consulting Group
Access the recording of the webcast and download related materials.
For questions, please contact the CAHPS User Network at cahps1@westat.com or 1-800-492-9261.
miércoles, 26 de junio de 2024
Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies Draft Guidance for Industry JUNE 2024
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/diversity-action-plans-improve-enrollment-participants-underrepresented-populations-clinical-studies?utm_medium=email&utm_source=govdelivery
Today, the U.S. Food and Drug Administration issued a draft guidance, “Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies,” to assist medical product sponsors in submitting Diversity Action Plans to support certain clinical studies. Diversity Action Plans are intended to increase clinical study enrollment of participants of historically underrepresented populations to help improve the data the agency receives about the patients who may potentially use the medical product.
In Conversation With...Stephen Hines, PhD and Monika Haugstetter, MHA, MSN, RN, CPHQ about TeamSTEPPS 3.0 Monika Haugstetter, MHA, MSN, RN, CPHQ; Stephen Hines, PhD | February 28, 2024
https://psnet.ahrq.gov/perspective/conversation-withstephen-hines-phd-and-monika-haugstetter-mha-msn-rn-cphq-about
Editor’s note: Monika Haugstetter, MHA, MSN, RN, CPHQ, is a Health Science Administrator with AHRQ, leading AHRQ’s TeamSTEPPS® initiative. Stephen Hines, PhD, is a Senior Research Scientist at the Arbor Research Collaborative for Health. While at Abt Associates, he co-led the TeamSTEPPS 3.0 revisions in collaboration with AHRQ. We spoke with Monika and Stephen about the newly released TeamSTEPPS 3.0 curriculum.
In Conversation with...Barbara Pelletreau and John Riggi about Cybersecurity Barbara Pelletreau, RN; John Riggi | March 27, 2024
https://psnet.ahrq.gov/perspective/conversation-withbarbara-pelletreau-and-john-riggi-about-cybersecurity
Editor’s note: John Riggi is the national advisor for cybersecurity and risk at the American Hospital Association. Barbara Pelletreau is a former senior vice president of patient safety for a large healthcare organization. We spoke to them about the risks of cybersecurity to patient safety and how organizations can prepare and respond to cyberattacks.
AHRQ National Webinar: Medication Without Harm - How Digital Healthcare Tools Can Support Providers and Improve Patient Safety July 27, 2024 | 2:30 - 4:00 PM ET
https://digital.ahrq.gov/
Medication Without Harm - How Digital Healthcare Tools Can Support Providers and Improve Patient Safety
Event Date: July 24, 2024 | 2:30pm – 4:00pm ET
https://digital.ahrq.gov/national-webinars/medication-without-harm-how-digital-healthcare-tools-can-support-providers-and
Unhealthy Alcohol Use Initiative - Findings Webinar
https://integrationacademy.ahrq.gov/news-and-events/news/unhealthy-alcohol-use-initiative-findings-webinar
June 27, 11 a.m. to noon ET: National Evaluation and Grantee Findings from the Unhealthy Alcohol Use in Primary Care Initiative. This webinar will highlight findings from AHRQ EvidenceNow: Managing Unhealthy Alcohol Use grantees who used quality improvement strategies to increase primary care screening, management and evidence-based treatment for unhealthy alcohol use. The fourth leading cause of preventable death in the United States, unhealthy alcohol use is associated with deteriorating mental and physical health as well as social and economic problems. Access information about webinar speakers and registration.
EvidenceNOW: Managing Unhealthy Alcohol Use
EvidenceNOW: Managing Unhealthy Alcohol Use: The COVID-19 pandemic has added to the problem with increased isolation, unemployment, and other stresses contributing to increased alcohol use.
AHRQ Grantee Profiles
AHRQ Grantee Profiles: These profiles highlight AHRQ research training grantees whose work has led to significant changes in health care policy and notably influenced research and practice. AHRQ supports a range of research training and career development grant programs that help emerging health services researchers better understand, improve, and share knowledge about how health care is delivered in the United States.
Data Infographics
Data Infographics: AHRQ's data infographics provide visual snapshots of health care trend data. These infographics highlight findings from the Agency’s Medical Expenditure Panel Survey (MEPS), the Healthcare Cost and Utilization Project (HCUP), and other AHRQ data sources. AHRQ’s infographics are available free of charge for posting on web sites, in newsletters, and on other platforms.
Treat-and-Release Emergency Department Utilization and Costs for Traumatic and Nontraumatic Dental Conditions, 2019 and 2020
Treat-and-Release Emergency Department Utilization and Costs for Traumatic and Nontraumatic Dental Conditions, 2019 and 2020
STATISTICAL BRIEF #305
March 2024
https://hcup-us.ahrq.gov/reports/statbriefs/sb305-dental-conditions-2019-2020.jsp
R. Henry Olaisen, Ph.D., M.P.H., P.M.P., and Marc Roemer, M.S.
Direct-to-consumer microbiome testing needs regulation The Lancet Gastroenterology & Hepatology
https://www.thelancet.com/journals/langas/issue/vol9no7/PIIS2468-1253(24)X0006-0
martes, 25 de junio de 2024
Safeguarding Health Information: Building Assurance through HIPAA Security 2024 - Save the Date! Safeguarding Health Information: Building Assurance Through HIPAA Security Conference (Oct 23-24, 2024)
https://www.nist.gov/news-events/events/2024/10/safeguarding-health-information-building-assurance-through-hipaa-security
The U.S. Department of Health and Human Services Office for Civil Rights (OCR) and the National Institute of Standards and Technology (NIST) are excited to announce the return of the “Safeguarding Health Information: Building Assurance through HIPAA Security” conference for October 2024. After a 5-year absence, the conference is returning to Washington, D.C.
DATES: October 23–24, 2024
LOCATION: HHS Headquarters (Hubert H. Humphrey Building) in Washington, D.C.
CONTENT: The conference will explore the current healthcare cybersecurity landscape and the Health Insurance Portability and Accountability Act (HIPAA) Security Rule. This event will highlight the present state of healthcare cybersecurity, and practical strategies, tips and techniques for implementing the HIPAA Security Rule. The Security Rule sets federal standards to protect the confidentiality, integrity and availability of electronic protected health information by requiring HIPAA covered entities and their business associates to implement and maintain administrative, physical and technical safeguards.
The conference will offer sessions that explore best practices in managing risks to and the technical assurance of electronic health information. Presentations will cover a variety of topics including managing cybersecurity risk and implementing practical cybersecurity solutions, understanding current cybersecurity threats to the healthcare community, cybersecurity considerations for the Internet of Things (IoT) in healthcare environments, updates from federal healthcare agencies, and more.
Unraveling the Mysteries of Biden vs. Trump on Health Care Drew Altman Published: Jun 24, 2024
https://www.kff.org/from-drew-altman/unraveling-the-mysteries-of-biden-vs-trump-on-health-care/?utm_campaign=KFF-Health-Policy-101&utm_medium=email&_hsenc=p2ANqtz-_08Db6AErCixRs8kcgtHFSbHQ2Golu5jBMgClCU_AV70VcjxRoZrQMcBK-D8hKNc5gBz37158Ki80UkcYl4Zg8I7G4Dw&_hsmi=312903414&utm_content=312903414&utm_source=hs_email
In Altman’s accompanying column, Unraveling the Mysteries of Biden vs Trump on Health Care, he writes that comparing the candidates on health care “was an especially tricky assignment” this time.
“With a president running for re-election whose policies are already set, and a former president who shuns policy details, both camps are skipping over the usual policy planning process, and the routine job of describing the differences between the two candidates on health issues is a thousand-piece puzzle,” Altman writes.
Beyond the specifics of the candidates’ records and positions on health issues, Altman writes, “the differences are bigger, amounting to a fork in the road in direction on the role of the federal government in health and federal health spending.” Trump, in particular, “avoids policy and policy details” so “the directions he might take have to be deduced from remarks he has made here and there, positions he took when he was president, and most of all, from the policy positions conservative Republican organizations have taken.”
Compare the Candidates on Health Care Policy
https://www.kff.org/compare-2024-candidates-health-care-policy/?utm_campaign=KFF-Health-Policy-101&utm_medium=email&_hsenc=p2ANqtz-_6IxxWVhOJboIUCU1EBeCV6WgS6rHNBNeyU0vEsd6-ZBPNrim0OsTNLoibOHgILkSGT5DMrzsKCl-d9NwHkLZDw94PrA&_hsmi=312903414&utm_content=312903414&utm_source=hs_email
The general election campaign has commenced, spotlighting President Biden and former President Trump as the presumptive nominees for their respective parties and the currently viable contenders for the presidency. While this is not an election like in the past where health care reform is a central issue being debated, health care is an important issue for voters and Biden and Trump have sharply divergent records and positions. This side-by-side analysis serves as a quick resource for understanding each candidate’s record as president, positions, public statements, and proposed policies. It will be continuously updated as new information and policy details emerge throughout the campaign.
CDER issues New Drugs Regulatory Program Modernization – Impact Narrative Update 2023
https://www.fda.gov/media/179517/download?attachment=&utm_medium=email&utm_source=govdelivery
The New Drugs Regulatory Program (NDRP) helps CDER achieve its mission to ensure human drugs are safe and effective and available to the American public. In 2017, CDER began an initiative to modernize NDRP, to continuously improve regulatory science and review. As part of this modernization initiative, CDER identified six strategic objectives and then, guided by these objectives, formed interdisciplinary workstreams to identify areas for improvement, develop recommendations, design changes, and drive implementation.
The report provides a detailed look at the strategic objectives and impact of NDRP modernization progress, as well as on continued efforts toward reaching program goals. This report illustrates how the progress thus far furthers NDRP’s ability to achieve its mission by staying ahead of the rapid growth and evolutions of drug development, review, and surveillance activity; the increasing complexity of innovative therapies under development; and the expanding public engagement between FDA and stakeholders.
Public Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Food Insecurity
https://www.uspreventiveservicestaskforce.org/uspstf/public-comments-and-nominations/opportunity-for-public-comment
The U.S. Preventive Services Task Force seeks comments on a draft recommendation statement and draft evidence review on screening for food insecurity. The Task Force found limited evidence on how screening in primary care can help address food insecurity. The draft recommendation statement and draft evidence review are available for review and public comment from June 25, 2024, to July 22, 2024
lunes, 24 de junio de 2024
Lessons from El Niño: gender-based violence must be on the agenda for future climate events The Lancet Regional Health – Americas
Lessons from El Niño: gender-based violence must be on the agenda for future climate events
The Lancet Regional Health – Americas
https://www.thelancet.com/journals/lanam/issue/vol34nonull/PIIS2667-193X(24)X0005-8
Suscribirse a:
Entradas (Atom)
